WO2012047762A3 - Agents antifongiques - Google Patents

Agents antifongiques Download PDF

Info

Publication number
WO2012047762A3
WO2012047762A3 PCT/US2011/054371 US2011054371W WO2012047762A3 WO 2012047762 A3 WO2012047762 A3 WO 2012047762A3 US 2011054371 W US2011054371 W US 2011054371W WO 2012047762 A3 WO2012047762 A3 WO 2012047762A3
Authority
WO
WIPO (PCT)
Prior art keywords
compounds
antifungal agents
useful
compositions
antifungals
Prior art date
Application number
PCT/US2011/054371
Other languages
English (en)
Other versions
WO2012047762A2 (fr
Inventor
Flórián TÓTH
Ronald Alan AUNGST Jr.
Atchyuta Rama Chandra Murty Bulusu
Robert Webb
Mitchell Mutz
Original Assignee
Amplyx Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amplyx Pharmaceuticals, Inc. filed Critical Amplyx Pharmaceuticals, Inc.
Publication of WO2012047762A2 publication Critical patent/WO2012047762A2/fr
Publication of WO2012047762A3 publication Critical patent/WO2012047762A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
    • A61K47/552—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds one of the codrug's components being an antibiotic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pest Control & Pesticides (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne des composés et des compositions utiles comme antifongiques, ainsi que des procédés d'utilisation et de préparation de tels composés et de compositions contenant de tels composés. Dans certains modes de réalisation, les composés sont bifonctionnels, et comprennent deux groupements actifs connectés par le biais d'un groupement de liaison. Les composés selon l'invention sont utiles pour traiter des infections par des micro-organismes.
PCT/US2011/054371 2010-10-08 2011-09-30 Agents antifongiques WO2012047762A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39155510P 2010-10-08 2010-10-08
US61/391,555 2010-10-08

Publications (2)

Publication Number Publication Date
WO2012047762A2 WO2012047762A2 (fr) 2012-04-12
WO2012047762A3 true WO2012047762A3 (fr) 2012-07-05

Family

ID=45928343

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2011/054371 WO2012047762A2 (fr) 2010-10-08 2011-09-30 Agents antifongiques

Country Status (1)

Country Link
WO (1) WO2012047762A2 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102659930B (zh) * 2012-03-30 2014-04-23 上海天伟生物制药有限公司 一种高纯度环肽类物质的晶体及其制备方法和用途
EP2746264A1 (fr) 2012-12-19 2014-06-25 Basf Se [1,2,4]triazole substitué et composés d'imidazole
WO2014095249A1 (fr) 2012-12-19 2014-06-26 Basf Se Composés d'imidazolyle et triazolyle fongicides
EP2746256A1 (fr) 2012-12-19 2014-06-25 Basf Se Composés triazolyles et imidazolyles fongicides
EP2746255A1 (fr) 2012-12-19 2014-06-25 Basf Se Composés de [1,2,4]triazole et d'imidazole substitués
EP2746279A1 (fr) 2012-12-19 2014-06-25 Basf Se Composés triazolyles et imidazolyles fongicides
WO2014095381A1 (fr) 2012-12-19 2014-06-26 Basf Se Composés imidazolyl et triazolyl fongicides
EP2746277A1 (fr) 2012-12-19 2014-06-25 Basf Se Composés triazolyles et imidazolyles fongicides
EP2746260A1 (fr) 2012-12-21 2014-06-25 Basf Se Composés de [1,2,4]triazole et d'imidazole substitués
EP2746259A1 (fr) 2012-12-21 2014-06-25 Basf Se Composés de [1,2,4]triazole et d'imidazole substitués
EP2746258A1 (fr) 2012-12-21 2014-06-25 Basf Se Composés de [1,2,4]triazole et d'imidazole substitués
EP2746257A1 (fr) 2012-12-21 2014-06-25 Basf Se Composés de [1,2,4]triazole et d'imidazole substitués
NZ710693A (en) 2013-03-01 2019-07-26 Fdc Ltd 1-substituted, 4-(substituted phenoxymethyl)-1,2,3-triazole compounds with antifungal properties and methods for preparation thereof
SG11201510011VA (en) 2013-06-07 2016-01-28 California Inst Biomedical Res Small molecule inhibitors of fibrosis
CN103387548B (zh) * 2013-08-08 2015-05-20 中国人民解放军第四○四医院 1,2,3-三唑类抗真菌化合物及其制备方法和应用
CN103450162B (zh) * 2013-08-08 2015-07-15 中国人民解放军第一○二医院 含有苯甲酰胺类结构的三氮唑醇类化合物及其制备方法和应用
WO2015106283A1 (fr) 2014-01-13 2015-07-16 Amplyx Pharmaceuticals, Inc. Composés antifongiques
US10336735B2 (en) 2014-12-10 2019-07-02 The Scripps Research Institute Small molecule inhibitors of fibrosis
CN104817508B (zh) * 2015-03-10 2017-12-05 中国人民解放军第二军医大学 一种三氮唑醇类衍生物及其制备方法和应用
JP2019534302A (ja) 2016-11-10 2019-11-28 ノバルティス アーゲー Ｂｍｐ増強剤
WO2021077242A1 (fr) * 2019-10-20 2021-04-29 鲁南贝特制药有限公司 Procédé de synthèse de caspofungine et intermédiaire associé

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040235798A1 (en) * 2001-07-05 2004-11-25 Murthi Krishna K Compositions and methods for inhibiting prenyltransferases
US20050209146A1 (en) * 1998-05-22 2005-09-22 Roger Briesewitz Administering bifunctional molecules containing a drug moiety and presenter protein ligand for therapy
WO2008082198A1 (fr) * 2006-12-29 2008-07-10 Daewoong Pharmaceutical Co., Ltd. Derivés triazoles antifongiques, leur procédé de préparation et composition pharmaceutique en contenant
WO2009055042A1 (fr) * 2007-10-24 2009-04-30 Amplyx Pharmaceuticals, Inc. Amélioration de l'efficacité de produits thérapeutiques anti-infectieux
WO2010065110A2 (fr) * 2008-12-01 2010-06-10 Amplyx Pharmaceuticals, Inc. Agents antimicrobiens

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050209146A1 (en) * 1998-05-22 2005-09-22 Roger Briesewitz Administering bifunctional molecules containing a drug moiety and presenter protein ligand for therapy
US20040235798A1 (en) * 2001-07-05 2004-11-25 Murthi Krishna K Compositions and methods for inhibiting prenyltransferases
WO2008082198A1 (fr) * 2006-12-29 2008-07-10 Daewoong Pharmaceutical Co., Ltd. Derivés triazoles antifongiques, leur procédé de préparation et composition pharmaceutique en contenant
WO2009055042A1 (fr) * 2007-10-24 2009-04-30 Amplyx Pharmaceuticals, Inc. Amélioration de l'efficacité de produits thérapeutiques anti-infectieux
WO2010065110A2 (fr) * 2008-12-01 2010-06-10 Amplyx Pharmaceuticals, Inc. Agents antimicrobiens

Also Published As

Publication number Publication date
WO2012047762A2 (fr) 2012-04-12

Similar Documents

Publication Publication Date Title
WO2012047762A3 (fr) Agents antifongiques
WO2010090860A3 (fr) Méthodes de traitement d'une infection bactérienne et compositions associées
WO2010063700A3 (fr) Nouveaux microbiocides
WO2009077497A3 (fr) Azolylméthyloxiranes, utilisation de ceux-ci et agents contenant ceux-ci
ZA200807274B (en) Novel pyridine derivatives
EA033311B1 (ru) Производные бензоксаборола в качестве антибактериальных средств
MX2009009948A (es) Derivados de piridazinona utiles como inhibidores de glucano sintasa.
IL221952A (en) Annotations 2, 3-Dihydro-1h - Indene-1-Il-7,2- Diazaspiro [5.3] Noonan and Pharmaceuticals Containing Them
WO2009024342A3 (fr) Nouveaux microbiocides
WO2011009539A8 (fr) CONJUGUÉS DE ε-POLYLYSINE ET LEUR UTILISATION
WO2009077471A3 (fr) Azolylméthyloxiranes, leur utilisation et agents les contenant
WO2009090237A3 (fr) Dérivés fongicides d'hydroximoyl-tétrazoles
WO2011160024A3 (fr) Composés utiles en tant qu'agents antiviraux, compositions, et procédés d'utilisation
TW200942524A (en) Novel aminomethyl benzene derivatives
WO2010149283A3 (fr) Phényloxy(thio)phénylamidobenzoxa(thia)zoles
WO2009127718A3 (fr) Nouveaux microbiocides
WO2011122872A3 (fr) Composition comprenant du coumestrol ou un extrait de fèves contenant du coumestrol
WO2012017321A3 (fr) Traitement de la dyslipidémie
WO2011080254A3 (fr) Dérivés hydroximoyl-hétérocycles fongicides
WO2011067209A3 (fr) Mélanges pesticides
WO2011130317A3 (fr) Agents thérapeutiques ayant une toxicité réduite
EP2332950A4 (fr) Composés de glycoside d épothilone, composition les utilisant comme principe actif et leur utilisation
WO2009103813A3 (fr) Compositions fongicides contenant du 3'-bromo-2,3,4,6'-tétraméthoxy-2'-6-diméthylbenzophénone
ATE483720T1 (de) Verbindungen enthaltend organofluorochlorophosphatanionen
WO2010065110A3 (fr) Agents antimicrobiens

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11831370

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11831370

Country of ref document: EP

Kind code of ref document: A2